← FDA Drug Approvals (Drugs@FDA)

PROCHLORPERAZINE EDISYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOMERSET THERAPS LLC · Approved 2024-09-13

Drug application

FDA Application #

ANDA212257

Application type

Abbreviated New Drug Application (Generic)

Brand name

PROCHLORPERAZINE EDISYLATE

Generic name

PROCHLORPERAZINE EDISYLATE

Active ingredients

PROCHLORPERAZINE EDISYLATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

SOMERSET THERAPS LLC

Manufacturer

Somerset Therapeutics, LLC

First approval

2024-09-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown